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Abstract
Background
The Gait Deviation Index summarizes overall gait ‘quality’, based on kinematic data from a
3-dimensional gait analysis. However, it is unknown which clinical outcomes may affect the
Gait Deviation Index in patients with primary hip osteoarthritis. The aim of this study was to
investigate associations between Gait Deviation Index as a measure of gait ‘quality’ and hip
muscle strength and between Gait Deviation Index and patient-reported outcomes in
patients with primary hip osteoarthritis.
Method
Forty-seven patients (34 males), aged 61.1 ± 6.7 years, with BMI 27.3 ± 3.4 (kg/m2) and
with severe primary hip osteoarthritis underwent 3-dimensional gait analysis. Mean Gait
Deviation Index, pain after walking and maximal isometric hip muscle strength (flexor,
extensor, and abductor) were recorded. All patients completed the ‘Physical Function
Short-form of the Hip disability and Osteoarthritis Outcome Score (HOOS-Physical Func-
tion) and the Hip disability and Osteoarthritis Outcome Score subscales for pain (HOOS-
Pain) and quality-of-life (HOOS-QOL).
Results
Mean Gait Deviation Index was positively associated with hip abduction strength
(p<0.01, r = 0.40), hip flexion strength (p = 0.01, r = 0.37), HOOS-Physical Function
(p<0.01, r = 0.41) HOOS-QOL (p<0.01, r = 0.41), and negatively associated with HOOS-
Pain after walking (p<0.01, r = -0.45). Adjusting the analysis for walking speed did not
affect the association.
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Conclusion
Patients with the strongest hip abductor and hip flexor muscles had the best gait ‘quality’.
Furthermore, patients with higher physical function, quality of life scores and lower pain lev-
els demonstrated better gait ‘quality’. These findings indicate that interventions aimed at
improving hip muscle strength and pain management may to a moderate degree improve
the overall gait ‘quality’ in patients with primary hip OA.
Introduction
Hip osteoarthritis (OA) is a leading cause of disability worldwide [1]. Patients with hip OA
walk more slowly, walk with altered gait pattern characteristics [2, 3] that are often reported as
limping gait [4] and have reduced hip muscle strength compared with healthy controls [5–8].
These impairments may also be reflected in patient-reported outcomes (PROs) [9, 10]. A study
by Amlie et al. 2014 showed that hip OA patients with self-reported limping gait after total hip
arthroplasty (THA) scored 17 to 35 points worse in PROs on all the subscales of Hip disability
and Osteoarthritis Outcome Score (HOOS) (0 = extreme symptoms to 100 = no symptoms)
compared with patients who reported no limping [11]. This indicates that the walking pattern
is important to patients post-operatively and may also be important prior to surgery. However,
limping gait is poorly defined and is often based on a subjective analysis performed by the
patient or the clinician.
Three-dimensional gait analysis (3DGA) is an objective and detailed analysis of the walking
pattern, with the possibility to measure a large number of discrete variables. Discrete variables
are often measured at one time-point in the gait cycle, for example hip or knee extension at ter-
minal stance or peak hip flexion and extension. However these discrete variables lack the ability
to evaluate the overall gait pattern or gait ‘quality’ throughout the entire gait cycle [12]. There-
fore, there is an increasing interest in implementing a summary index that describes the overall
gait ‘quality’ expressed as the degree of deviation from normalcy. The most common overall
gait index used to date is the Gillette Index, but several limitations have been raised. The selec-
tion of variables included in the Gillette Index was largely based on gait deviation experienced
in children with cerebral palsy and only the characteristic discrete time-points in the gait cycle
were included [13]. In contrast, the Gait Deviation Index (GDI) was developed with the inten-
tion of providing an overall gait ‘quality’ index [14]. GDI summarizes the lower limb kinematic
of nine variables for each limb throughout the entire gait cycle into one single value that
describes 98% of the variation in gait. The nine variables included in the GDI are kinematics
from: pelvic and hip in sagittal, frontal and transversal plane, knee and ankle in the sagittal
plane and foot progression [14]. The GDI expresses the degree of gait pathology in patients
compared with a healthy reference group [14]. This removes the subjectivity in the choice of
discrete parameters. Furthermore, the selection of the parameters for the Gillette Index was
specific for children with cerebral palsy, whereas the GDI is considered a general measure of
the overall gait pathology or gait ‘quality’ in humans [14]. The GDI has been applied on differ-
ent patient groups ranging from patients with cerebral palsy [15–18] to patients with hip OA
[19, 20], patients with rheumatoid arthritis [21] and patients with Parkinson’s Disease [22].
Research into associations between the GDI as a measure of gait ‘quality’ and validated clini-
cally important outcomes will improve understanding of the clinical utility and application of
the GDI in research and in the clinical context. This has, to our knowledge, only been per-
formed in cerebral palsy and rheumatoid arthritis patients [18, 21, 23].
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The purpose of this study was to investigate potential associations between gait ‘quality’
measured by the GDI, hip muscle strength and PROs in patients with severe primary hip OA.
We hypothesized that low hip muscle strength, high pain level and impaired self-reported
physical function and quality of life would be associated with reduced GDI scores. The results
from this study will provide a better understanding of the factors influencing the overall gait
‘quality’ and the way in which targeted rehabilitation may improve gait ‘quality’ for hip OA
patients.
Materials and Methods
Design
This study was a cross-sectional analysis of explorative pre-operative data from a subsample of
patients included in a randomized controlled trial. The trial is registered at ClinicalTrials.gov.
No.:NCT01616667 and described in detail elsewhere [24].
Participants
Forty-seven patients were recruited from the outpatient clinic at the Department of Orthopae-
dic Surgery and Traumatology, Odense University Hospital and Svendborg Hospital (SvB),
Denmark between May 2012 and May 2014. The inclusion criteria were patients aged 45–70
years with primary unilateral hip OA, scheduled for cementless THA. Patients were excluded if
they had had prior THA or major lower limb surgery, BMI>35 (kg/m2) (due to difficulties
with gait analysis marker placement), if they were unable to walk without walking aid of any
kind, if they had any neurological or medical disease compromising their walking ability,
inability to read and understand Danish, or if they declined to participate. All patients were
clinically and radio-graphically evaluated and diagnosed with primary OA and scheduled for
THA. A convenience sample of 20 able-bodied adults aged 45 to 70 years was recruited to pro-
vide a reference group on kinematic data.
The patients’ characteristics are summarized in Table 1. Forty-seven patients and 20 able-
bodied participants completed the evaluation with 3DGA and hip muscle iMVC. The patient
group included 34 males and 13 females. They had a mean age of 61.1 ± 6.7 years and a mean
BMI of 27.3 ± 3.4 (kg/m2).
The able-bodied participants (55% female) had a mean age of 59.6 ±7.1 years and mean
BMI of 25.6 ±2.9 (kg/m2), Table 1. The able-bodied participants walked, as expected, signifi-
cantly faster than the OA patients (p< 0.01).
The trial complied with the Declaration of Helsinki. It was approved by the Danish Data
Protection Agency and The Danish Regional Committee on Biomedical Research Ethics
(Southern Denmark), Project-ID S-20120009. A written and orally informed consent was col-
lected prior to the inclusion of all participants.
Gait data collection
3DGA data were collected using a six-camera motion capture system (Vicon MX03, Oxford,
UK) and further processed in Nexus 1.7–8 [25, 26]. Prior to the gait analysis the leg length, pel-
vic, knee and angle width were measured. These measurements were used to estimate joint
rotation centres for each individual. A total of 16 markers were placed on anatomical land-
marks on the pelvic, thigh, knee and foot according the standardized Plug-in-Gait marker set
model [27]. All the participants walked barefooted at self-selected walking speed on a 10 meter
long walking corridor. The patients and able-bodied participants completed an identical
motion capture protocol. We captured five separate gait trials for each participant as
Gait Deviation Index and Hip Muscle Strength
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recommended by Laroche et al. 2011 [28]. To avoid acceleration and deceleration only the
stride in the centre of the capturing volume for each trial (five left and five right) were
analysed.
Maximal hip muscle strength
The muscle strength of the hip abductor, hip flexor and hip extensor muscles was measured
with three consecutive isometric maximal voluntary contractions (iMVC) for each muscle
group. Maximal hip muscle strength was recorded in the upright standing position, according
to the protocol described by Jensen et al. [29]. For each muscle group, one submaximal test
contraction (for familiarization) and three maximal contractions were performed. The partici-
pants received both visual feedback on a pc-monitor (in the form of a graphical plot of the
force over time) and verbal feedback during each test contraction. To avoid a systematic learn-
ing bias, two dice randomizations were used to determine first the starting leg and second the
sequence of muscle groups to be tested. The two data collectors performed a visual inspection
(face validity) together of the contraction curves to ensure no pretension using a custom-made
MATLAB1 program (MathWorks, Natick, MA, US). The contraction with the highest peak
moment (Nm) was selected and normalized according to body mass (Nm/kg). Only iMVC per-
formed with the affected limb was used in the current study. iMVC in the standing position
has shown acceptable validity [30] and high test-retest reliability has been reported in healthy
adults and patients with THA [29, 30].
Pain assessment
Pain was measured immediately after completion of the 3DGA using an 11-point (0–10)
Numeric Rating Scale (NRS); where 0 represents ‘no pain’ and 10 represents ‘the worst possible
pain’. The patients were asked to assess their hip pain intensity for the affected limb immedi-
ately after walking. A second pain intensity assessment was performed immediately after the
last iMVC contraction. The NRS scores for the affected limbs recorded after walking were used
in the association analyses. The NRS has been shown to be both valid and reliable in geriatric
patients [31].
Patient-reported outcome measures
We used the Hip disability and Osteoarthritis Outcome Score–Physical Function Short-form
together with its subscales of Pain and Quality Of Life in HOOS 2.0 (HOOS-Pain and HOOS--
QOL) to measure physical function, pain and quality of life, respectively. The total score for
each of the three subscales ranges from 0 points (extreme symptoms) to 100 points (no
Table 1. Characteristics of hip OA patients and able-bodied.
Characteristics Hip OA-patients (n = 47) Able-bodied (n = 20) P-value
Age (years), mean ± SD 61.1 ± 6.7 56.9 ± 7.1 0.02a
Male (%) 34 (72) 9 (45) 0.03b
BMI (kg/m2), mean ± SD 27.3 ± 3.4 25.6 ± 2.9 0.05a
Self-selected walking speed (m/s), mean ± SD 1.12 ± 0.18 1.33 ± 0.14 < 0.01a
Affected side (Right) 25 Not relevant -
Abbreviations: OA = Osteoarthritis; SD = standard deviation; BMI = body mass index
a Independent unpaired t-test with equal variance
b Pearson’s chi2 test
doi:10.1371/journal.pone.0153177.t001
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symptoms). HOOS-Physical Function has shown good validity when compared with the
HOOS subscale for Activity of Daily Living and high responsiveness in THA patients [32].
HOOS 2.0 has shown high validity, reliability and responsiveness in patients diagnosed with
hip OA [33]. The patients completed the Danish version of the questionnaire that has been val-
idated for trans-cultural adaptation [34].
Data processing
The GDI is calculated for each limb using nine kinematic variables collected during 3DGA-
namely, all three planes from the pelvis and hip, the sagittal plane from the knee and ankle and
the foot progression [14]. First, the GDI scores for the 20 able-bodied participants were calcu-
lated according to the instructions described by its authors using the electronic addendum (an
Microsoft Excel file) provided with the original paper by Schwartz and Rozumalski 2008 [14].
We validated our reference group data based on the original reference data of typically develop-
ing children [14] and found that our reference group had a mean GDI (mGDI) of 94.4 ± 7.3
Next, we replaced the original reference data in the electronic addendum with our reference
group data–which per se had an index value of 100. Finally, we calculated the GDI scores for
the hip OA patients against our reference group data. mGDI scores based on five trials were
calculated. We only used the mGDI of the affected limbs in the analyses. A GDI score of 100 or
above represents no gait pathology. Each 10-point decrement from 100 indicates approxi-
mately one standard deviation from the normal gait pattern [14]. GDI has shown good validity
in children with cerebral palsy [35] and excellent inter-trial and intra-rater reliability [16, 21].
Statistical Analysis
Data were checked for completeness and normality (Q-Q plot). A one-sample t-test was used
to test the difference between the patients’ mGDI and the reference group’s GDI of 100 points.
We used Pearson’s correlation to investigate the associations between mGDI and continu-
ous variables (iMVC in hip flexion, extension and abduction, HOOS-Physical Function,
HOOS-Pain and HOOS-QOL). Spearman correlation was used to investigate the association
between mGDI and pain measured by the NRS (ordinal data). Preliminary analyses were per-
formed to ensure all correlation analysis assumptions were fulfilled and data were checked for
linearity and outliers (Fig 1A and 1B. representative examples). Further, multiple linear regres-
sion was used to investigate the associations adjusting for walking speed. Walking speed has an
influence on the kinematic in the lower limb [36, 37] and it has also been shown that the GDI
may be affected by gait speed [38]. The correlation coefficients (r-value) and the determination
coefficient (R2) were reported. The correlation coefficients were interpreted according to Dan-
cey and Reidy [39]: an r-value of 0.1–0.3 was regarded as weak; 0.4–0.6 as moderate; 0.7–0.9 as
strong and 1 as perfect correlation. The statistical analyses were performed using Stata 13.1
(Stata Corp LP, Brownsville, TX, US) and we used a 0.05 significance level.
Results
The descriptive clinical data are summarized in Table 2. Hip OA patients had moderately
decreased mGDI scores on the affected limb compared with the reference group (87.9 ± 9.1 vs.
100, p<0.01).
Results from the unadjusted and adjusted associations between the mGDI scores and the
independent clinical outcomes are summarized in Table 3. A significant, moderate association
between hip abduction muscle strength and mGDI was identified (r = 0.40; p<0.01). We also
found a significant, albeit weak, association between hip flexion muscle strength and mGDI
(r = 0.37; p = 0.01), but no association between hip extension muscle strength and mGDI
Gait Deviation Index and Hip Muscle Strength
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Fig 1. A-B. Representative examples of the association between mGDI and clinical outcomes.
doi:10.1371/journal.pone.0153177.g001
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(r = 0.10; p = 0.50). Adjusting for walking speed did not change the significance of the associa-
tion between mGDI and hip muscle strength, Table 3.
We found a moderately significant negative association between pain measured by NRS
immediately after walking and mGDI (r = -0.45; p<0.01), Table 3. Furthermore, moderately
significant associations between mGDI and patient-reported physical function and quality of
life (r = 0.41; p<0.01 and r = 0.41; p<0.01, respectively) were found. These moderately signifi-
cant associations were also present after adjusting for walking speed, Table 3. However; no
association between mGDI and HOOS-Pain was found (r = 0.18; p = 0.23).
Discussion
This study investigated the potential influence of hip muscle strength, patient-reported physi-
cal function, pain and quality of life on the gait ‘quality’ of patients with hip OA.
Hip muscle strength and gait ‘quality’
The results confirmed our hypotheses that hip OA patients who experience low hip muscle
strength also walk with reduced gait ‘quality’, but to a lesser degree than anticipated. The cur-
rent weak to moderate associations emphasize that reduced iMVC does not reflect the entire
functional limitation of gait suggesting that factors not identified in the current study are also
of importance for gait ‘quality’. However, our results are consistent with previous findings of
weak to moderate associations between hip abductor muscle strength and discrete kinematic
Table 2. Descriptive outcome data for the patients: mean Gait Deviation Index, hip muscle strength
and pain for the affected limb and patient-reported outcomemeasures.
Variables Hip OA-patients
(n = 47)
Mean GDI (0  100) in affected limb,
mean ± SD
GDI 87.9 ± 9.1
Hip muscle strength in affected limb,
mean ± SD
Hip Extension (Nm/kg) 2.28 ± 0.55
Hip Flexion (Nm/kg) 1.32 ± 0.38
Hip Abduction (Nm/kg) 1.62 ± 0.36
NRS-pain (0–10) in affected limb, median
(Q1;Q3)
After walking 5 (2;6)
Number of patients’ with NRS > 5
(%)
17 (36%)
After muscle strength test 6 (3;8)
Number of patients’ with NRS > 5
(%)
24 (51%)
HOOS subscales (0–100), mean ± SD
HOOS-Physical Function 51.8 ± 16.2
HOOS-Pain 43.4 ± 15.8
HOOS-Quality of Life 29.0 ± 14.5
Q1; Q3 represent 25th and 75th percentiles. Abbreviations: OA = Osteoarthritis; GDI = Gait Deviation Index;
NRS = Numeric Rating Scale for pain (0 represents ‘no pain’ and 10 represents ‘the worst possible pain’);
HOOS = Hip disability and Osteoarthritis Outcome Score ranges from 0 = extreme symptoms to 100 = no
symptoms
doi:10.1371/journal.pone.0153177.t002
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variables of gait in hip OA patients and healthy older adults [12, 40]. The GDI was measured
during horizontal walking at a self-selected walking speed. This task may not be challenging
enough to ensure high demand on the hip muscles in hip OA patients, which is reflected in the
weak to moderate association. This may also be the reason why we did not find any association
between mGDI and hip extensor muscle strength. Little strength requirements in this muscle
group is needed during horizontal walking [41]. The hip muscle strength was measured
isometrically in a standing position with the limb in an anatomically neutral position. How-
ever, this position only represents the position of the joint at one time point in the gait cycle.
Analysis of measures of isokinetic hip muscle strength in a dynamic setup mimicking the range
of motion and force-velocity during gait may supply the analysis and represent a more func-
tional model. Our finding of a positive association between hip abductor muscle strength and
mGDI is however in line with several previous studies that found hip abductor muscle strength
to be important for gait function and emphasized the need for increased muscle strengthening
regimens [5, 42–45]. The hip abductors are important to stabilize the pelvis in the frontal plane
during the stance phase and hip abductor weakness may cause the pelvis to drop towards the
swing limb [46] and thus influence the kinematic of the pelvis included in the GDI. Our results
suggest that an effective rehabilitation intervention with special focus on the hip abductor mus-
cles will, to some extent, improve the gait ‘quality’ for patients with hip OA although it only
accounted for 16% of the variation in gait. Thus, this study contributed to identify adjustable
physical parameters that influence the gait ‘quality’. It is essential to identify these parameters
and know the strength of associations to gait when developing rehabilitation programs that
intend to improve the overall gait in patients with hip OA.
Pain and gait ‘quality’
We found a moderately negative association between gait ‘quality’ and pain measured directly
after walking that explained 20% of the variation in GDI but we found no association between
gait ‘quality’ and pain measured over the past week (HOOS-pain). The discrepancy in our
results could be explained by the way the two pain score are collected. The NRS score is directly
connected to the pain level experienced by the patient at the time of walking, whereas the items
in the HOOS-pain subscale cover several situations over the past week, not only related to the
activity of walking. In accordance with our result, both Behery and Foucher 2014 and Zeni
Table 3. Simple and adjusted associations betweenmGDI as the dependent variable and hip muscle strength, pain and HOOS scores as indepen-
dent variables.
Independent outcome variables Simple association* Adjusted association**
r-value R2 P-value r-value R2 P-value
Hip Extension 0.10 0.01 0.50 0.33 0.11 0.08
Hip Flexion 0.37 0.13 0.01 0.41 0.17 0.02
Hip Abduction 0.40 0.16 <0.01 0.43 0.19 0.01
NRS-pain after walking -0.45 0.20 <0.01 -0.48 0.23 <0.01
HOOS-Physical Function 0.41 0.17 <0.01 0.45 0.20 <0.01
HOOS-Pain 0.18 0.03 0.23 0.35 0.12 0.06
HOOS-Quality of Life 0.41 0.17 <0.01 0.50 0.25 <0.01
* Continuous data analysed with Pearson’s correlation and ordinal data analysed with Spearman correlation
** Multiple linear regressions adjusting for walking speed
Abbreviations: OA = Osteoarthritis; GDI = Gait Deviation Index; NRS = Numeric Rating Scale for pain; HOOS = Hip disability and Osteoarthritis Outcome
Score
doi:10.1371/journal.pone.0153177.t003
Gait Deviation Index and Hip Muscle Strength
PLOS ONE | DOI:10.1371/journal.pone.0153177 April 11, 2016 8 / 13
et al. 2014 [10, 12] investigated the association between pain measured as the average over the
last week and discrete 3DGA parameters and they found no association in patients with hip
OA. Thus, our finding suggests that high pain level experienced directly in relation to gait is
negatively associated with the objective measured gait ‘quality’ and that it matters at which
time-point pain is measured. Our results imply that interventions aimed at improving pain
management may improve gait ‘quality’ to a moderate degree in patients with severe hip OA.
Patient-reported outcomes and gait ‘quality’
The moderate association between mGDI and self-reported physical function and quality of life
is also in agreement with previous findings [10]. Associations between the Harris Hip Score
(HHS) (which is a commonly used surgeon-reported outcome measure) and several specific gait
variables (hip range of motion and joint moments in all three planes of the hip) before and after
THA surgery have been identified [10]. An association between the HHS subscale of physical
function and kinematic gait parameters, in particular, has been observed [10]. The variance not
accounted for between mGDI and PROs in this study may be because self-reported physical
function and actual physical performance are two different constructs, but hypothesized to have
some similarities. Therefore, strong associations cannot be expected. However, our results under-
line that both types of measurement are important to obtain a more complete evaluation of hip
OA patients [47, 48]. Further this study has shown an association between patient-reported out-
come and gait ‘quality’. These findings indicate that gait ‘quality’ may be important for the well-
being of patients with hip OA as it has been shown for patients with THA [11].
Interactions of outcomes between domains
As recommended by ‘Outcome Measures in Rheumatology Clinical Trials’ [49], evaluation of
both objective and patient-reported measures was performed in the current study. However, in
this study, we did not investigate the associations between hip muscle strength and PROs
directly, but it has previously been shown that improving the hip abductors significantly
improves both pain and patient-reported physical function in people with knee OA [50] and
hip OA [47, 51]. Thus, improvement of hip abductor strength would possibly improve both
physical function and gait ‘quality’ in hip OA patients.
We have also investigated the interaction between different domains in accordance with
WHO International Classification of Functioning, Disability and Health (ICF) classification
[52]. The ICF classification specifies three domains (‘body function’, ‘activity’ and ‘participa-
tion’) that influence a person’s functioning, disability and health status and the model implies
that the domains are interacting. This study covered two of the domains, namely, ‘body func-
tion’ with the measure of gait ‘quality’ and hip muscle strength and the ‘participation’ domain
reflected in the PROs. We observed weak to moderate associations both within the domain of
‘body function’ (gait ‘quality’ and hip muscle strength) and between the domains (gait ‘quality’
and PROs) supporting the interaction between the domains.
Strengths and limitations
We conducted an explorative study on a well-defined patient group with unilateral hip OA,
which supports the internal validity of the study. The use of the GDI as a measure of gait ‘qual-
ity’ has advantages over more common ways of reporting the results from 3DGA. Firstly, by
reporting a single composite score rather than several discrete gait variables extracted at spe-
cific time points in the gait cycle, the GDI can be used as an overall score of gait pathology. Sec-
ondly, the GDI has shown previously to be a potentially useful classification and evaluation
tool in different patients [15, 18, 19, 21, 22, 53]. Furthermore, we based the GDI calculation
Gait Deviation Index and Hip Muscle Strength
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upon 3DGA data collected on an adult abled-bodied reference group in our own laboratory
instead of using the reference data from the literature based upon typically developing children
[14]. Walking speed is known to influence the kinematic parameters [36, 37, 54]; however, all
significant results remained significant after adjusting for walking speed, which shows robust-
ness in our findings.
Finally, the evaluation included the valid and reliable HOOS-questionnaire, pain measured
directly related to the gait analysis session and measurement of hip muscle strength. Thus, our
results may be one step towards providing ‘validity’ to the use of the GDI in hip OA patients.
However, limitations of the current study should be mentioned. Firstly, limitations with
regard to 3DGA methodology made strict inclusion criteria necessary [24]. This can affect the
external validity of the study. Secondly, the GDI score does not provide any information of the
underlying cause of the deviations from normal gait and does not include tempo-spatial
parameters or kinetic data. Thirdly, pain during testing may limit the measurements of iMVC,
because pain potentially reduces the patient’s effort in reaching maximal strength [55]. As
twenty-four (51%) patients in our study had NRS pain scores of five or above after the iMVC
test, (Table 2), this may have affected the association between the GDI and hip muscle strength.
Finally, it must be emphasized that this is an explorative cross-sectional study where clear
causal relationships cannot be established. A prospective intervention study investigating if
improving the maximal hip muscle strength improves the gait ‘quality’, as this cross-sectional
study implies, is therefore warranted.
Conclusion
Better hip flexor and hip abductor muscle strength were weakly to moderately associated with
a better gait ‘quality’ in patients with hip osteoarthritis. Furthermore, patients with higher
patient-reported physical function, quality of life and lower pain levels demonstrated better
gait ‘quality’. Interventions aimed at improving hip muscle strength, especially hip abduction
strength, and appropriate pain management may to a moderate degree improve the gait ‘qual-
ity’ in patients with severe hip osteoarthritis. This, however, needs to be confirmed in con-
trolled intervention studies.
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